Protez Pharmaceuticals Report issue

For profit Phase 2
Founded: Malvern PA United States (2003)
Status: Acquired by Novartis (2008)

Organization Overview

First Clinical Trial
2008
NCT00671580
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree